Malattia di Creutzfeldt-Jakob (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malattia di Creutzfeldt-Jakob" in Italian language version.

refsWebsite

Global rank Italian rank

20nih.gov

4^th place

9^th place

18doi.org

2^nd place

7^th place

12web.archive.org

1^st place

9oadoi.org

799^th place

22^nd place

5archive.org

6^th place

8^th place

2worldcat.org

5^th place

26^th place

2unibo.it

4,963^rd place

325^th place

2ajnr.org

low place

1orpha.net

3,537^th place

1,385^th place

1rarediseases.org

5,181^st place

low place

1bmj.com

1,226^th place

928^th place

1archive.today

14^th place

11^th place

1merckmanuals.com

3,097^th place

4,916^th place

1ajol.info

8,971^st place

6,403^rd place

1nature.com

234^th place

226^th place

1who.int

195^th place

342^nd place

1trasfusione.ch

low place

1msn.com

117^th place

266^th place

1oxfordjournals.org

1,389^th place

732^nd place

1bionosis.com

low place

1utah.edu

2,446^th place

5,141^st place

1bbc.co.uk

8^th place

23^rd place

ajnr.org

Geoffrey S. Young, G, F, M, H, L, L, W e L, Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt–Jakob Disease: High Sensitivity and Specificity for Diagnosis, in American Journal of Neuroradiology, vol. 26, n. 6, American Society of Neuroradiology, giugno–luglio 2005, pp. 1551–1562, PMID 15956529. URL consultato il 30 ottobre 2007.
Henriette J. Tschampa, M, F, P, S e U, Thalamic Involvement in Sporadic Creutzfeldt–Jakob Disease: A Diffusion-Weighted MR Imaging Study, in American Journal of Neuroradiology, vol. 24, n. 5, American Society of Neuroradiology, 1º maggio 2003, pp. 908–915, PMID =12748093. URL consultato il 30 ottobre 2007.

ajol.info

Obi RK, Nwanebu FC, Prions And Prion Diseases, in African Journal of Clinical and Experimental Microbiology, vol. 9, n. 1, 2008, pp. 38–52, ISSN 1595-689X (WC · ACNP). URL consultato il 20 giugno 2009.

archive.org

Gambetti P, Kong Q, Zou W, Parchi P, Chen SG, Sporadic and familial CJD: classification and characterisation, in Br. Med. Bull., vol. 66, 2003, pp. 213–39, DOI:10.1093/bmb/66.1.213, PMID 14522861.
Jones M, Peden AH, Prowse CV, In vitro amplification and detection of variant Creutzfeldt–Jakob disease PrPSc, in J. Pathol., vol. 213, n. 1, settembre 2007, pp. 21–6, DOI:10.1002/path.2204, PMID 17614097.
Mills JL, Schonberger LB, Wysowski DK, Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients, in The Journal of Pediatrics, vol. 144, n. 4, aprile 2004, pp. 430–6, DOI:10.1016/j.jpeds.2003.12.036, PMID 15069388.
Belay ED, Schonberger LB, Variant Creutzfeldt–Jakob disease and bovine spongiform encephalopathy, in Clin. Lab. Med., vol. 22, n. 4, 2002, pp. 849–62, v–vi, DOI:10.1016/S0272-2712(02)00024-0, PMID 12489284.
Pfeifer A, Eigenbrod S, Al-Khadra S, Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice, in The Journal of Clinical Investigation, vol. 116, n. 12, dicembre 2006, pp. 3204–10, DOI:10.1172/JCI29236, PMC 1679709, PMID 17143329.

archive.today

(EN) Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, Fumiaki Tanaka, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Mikio Hirayama e Gen Sobue, MM2-cortical-type sporadic Creutzfeldt–Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course (abstract), in Neuropathology, vol. 28, n. 6, dicembre 2008, pp. 645–51, DOI:10.1111/j.1440-1789.2008.00904.x, PMID 18410280 (archiviato dall'url originale il 5 gennaio 2013).

bbc.co.uk

news.bbc.co.uk

Teenager with vCJD stable, su news.bbc.co.uk, London, BBC News, 13 dicembre 2004. URL consultato il 1º gennaio 2007.

bionosis.com

SOFIA: An Assay Platform for Ultrasensitive Detection of PrP^Sc in Brain and Blood (PDF), su bionosis.com, SUNY Downstate Medical Center. URL consultato il 19 agosto 2011.

bmj.com

Paul Brown, Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease, BMJ, 4 luglio 2001. URL consultato il 23 febbraio 2011.

doi.org

dx.doi.org

Gambetti P, Kong Q, Zou W, Parchi P, Chen SG, Sporadic and familial CJD: classification and characterisation, in Br. Med. Bull., vol. 66, 2003, pp. 213–39, DOI:10.1093/bmb/66.1.213, PMID 14522861.
(EN) Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, Fumiaki Tanaka, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Mikio Hirayama e Gen Sobue, MM2-cortical-type sporadic Creutzfeldt–Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course (abstract), in Neuropathology, vol. 28, n. 6, dicembre 2008, pp. 645–51, DOI:10.1111/j.1440-1789.2008.00904.x, PMID 18410280 (archiviato dall'url originale il 5 gennaio 2013).
Wang XF, Dong CF, Zhang J, Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro, in Mol. Cell. Biochem., vol. 310, 1–2, marzo 2008, pp. 49–55, DOI:10.1007/s11010-007-9664-6, PMID 18038270.
Hamaguchi T, Noguchi-Shinohara M, Nozaki I, The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures, in Neuropathology, vol. 29, n. 5, ottobre 2009, pp. 625-31, DOI:10.1111/j.1440-1789.2009.01023.x, PMID 19659942.
Jones M, Peden AH, Prowse CV, In vitro amplification and detection of variant Creutzfeldt–Jakob disease PrPSc, in J. Pathol., vol. 213, n. 1, settembre 2007, pp. 21–6, DOI:10.1002/path.2204, PMID 17614097.
Will RG, Ironside JW, Zeidler M, A new variant of Creutzfeldt–Jakob disease in the UK, in Lancet, vol. 347, n. 9006, aprile 1996, pp. 921–5, DOI:10.1016/S0140-6736(96)91412-9, PMID 8598754.
Chakraborty C, Nandi S, Jana S, Prion disease: a deadly disease for protein misfolding, in Current Pharmaceutical Biotechnology, vol. 6, n. 2, aprile 2005, pp. 167–77, DOI:10.2174/1389201053642321, PMID 15853695.
Manuelidis L, Yu ZX, Barquero N, Banquero N, Mullins B, Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles, in Proceedings of the National Academy of Sciences of the United States of America, vol. 104, n. 6, febbraio 2007, pp. 1965–70, DOI:10.1073/pnas.0610999104, PMC 1794316, PMID 17267596.
Mills JL, Schonberger LB, Wysowski DK, Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients, in The Journal of Pediatrics, vol. 144, n. 4, aprile 2004, pp. 430–6, DOI:10.1016/j.jpeds.2003.12.036, PMID 15069388.
(EN) M.E. Bruce, R.G. Will, J.W. Ironside, I. McConnell, D Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser e C.J. Bostock, Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent, in Nature, vol. 389, n. 6650, NY, NY, Nature Publishing Group, 2 ottobre 1997, pp. 498-501, DOI:10.1038/39057, ISSN 0028-0836 (WC · ACNP). URL consultato il 25 aprile 2012.
McDonnell G, Burke P, The challenge of prion decontamination, in Clinical Infectious Diseases, vol. 36, n. 9, maggio 2003, pp. 1152–4, DOI:10.1086/374668, PMID 12715310.
Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient, in Lancet, vol. 364, n. 9433, 2004, pp. 527–9, DOI:10.1016/S0140-6736(04)16811-6, PMID 15302196.
Regan F, Taylor C, Blood transfusion medicine, in BMJ (Clinical Research Ed.), vol. 325, n. 7356, luglio 2002, pp. 143–7, DOI:10.1136/bmj.325.7356.143, PMC 1123672, PMID 12130612.
Sanchez-Juan, P., Green, A., Ladogana, A., et al., CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease, in Neurology, vol. 67, n. 4, 2006, pp. 637–643, DOI:10.1212/01.wnl.0000230159.67128.00, PMID 16924018.
Tattum, M. H., Jones, S., Pal, S., Khalili-Shirazi, A., Collinge, J., Jackson, G., A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K, in Transfusion, vol. 50, n. 12, AABB, dicembre 2010, pp. 2619–2627, DOI:10.1111/j.1537-2995.2010.02731.x, PMID 20561299.
Belay ED, Schonberger LB, Variant Creutzfeldt–Jakob disease and bovine spongiform encephalopathy, in Clin. Lab. Med., vol. 22, n. 4, 2002, pp. 849–62, v–vi, DOI:10.1016/S0272-2712(02)00024-0, PMID 12489284.
Rainov NG, Tsuboi Y, Krolak-Salmon P, Vighetto A, Doh-Ura K, Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?, in Expert opinion on biological therapy, vol. 7, n. 5, 2007, pp. 713–26, DOI:10.1517/14712598.7.5.713, PMID 17477808.
Pfeifer A, Eigenbrod S, Al-Khadra S, Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice, in The Journal of Clinical Investigation, vol. 116, n. 12, dicembre 2006, pp. 3204–10, DOI:10.1172/JCI29236, PMC 1679709, PMID 17143329.

merckmanuals.com

Pierluigi Gambetti, Creutzfeldt-Jakob Disease (CJD), su merckmanuals.com, The Merck Manuals: Online Medical Library. URL consultato il 4/6/11.

msn.com

msnbc.msn.com

By Rachael Rettner, Blood test may screen for human form of mad cow, MSNBC, 3 febbraio 2011. URL consultato il 9 febbraio 2011.

nature.com

(EN) M.E. Bruce, R.G. Will, J.W. Ironside, I. McConnell, D Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser e C.J. Bostock, Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent, in Nature, vol. 389, n. 6650, NY, NY, Nature Publishing Group, 2 ottobre 1997, pp. 498-501, DOI:10.1038/39057, ISSN 0028-0836 (WC · ACNP). URL consultato il 25 aprile 2012.

nih.gov

ncbi.nlm.nih.gov

VeriMed Healthcare Network, reviewed by: David C. Dugdale, Luc Jasmin,David Zieve, Creutzfeldt-Jakob disease: Transmissible spongiform encephalopathy; vCJD; CJD; Jacob-Creutzfeldt disease, U.S. National Library of Medicine, 26 settembre 2011. URL consultato il 25 aprile 2012.
Gambetti P, Kong Q, Zou W, Parchi P, Chen SG, Sporadic and familial CJD: classification and characterisation, in Br. Med. Bull., vol. 66, 2003, pp. 213–39, DOI:10.1093/bmb/66.1.213, PMID 14522861.
(EN) Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, Fumiaki Tanaka, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Mikio Hirayama e Gen Sobue, MM2-cortical-type sporadic Creutzfeldt–Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course (abstract), in Neuropathology, vol. 28, n. 6, dicembre 2008, pp. 645–51, DOI:10.1111/j.1440-1789.2008.00904.x, PMID 18410280 (archiviato dall'url originale il 5 gennaio 2013).
Wang XF, Dong CF, Zhang J, Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro, in Mol. Cell. Biochem., vol. 310, 1–2, marzo 2008, pp. 49–55, DOI:10.1007/s11010-007-9664-6, PMID 18038270.
Hamaguchi T, Noguchi-Shinohara M, Nozaki I, The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures, in Neuropathology, vol. 29, n. 5, ottobre 2009, pp. 625-31, DOI:10.1111/j.1440-1789.2009.01023.x, PMID 19659942.
Jones M, Peden AH, Prowse CV, In vitro amplification and detection of variant Creutzfeldt–Jakob disease PrPSc, in J. Pathol., vol. 213, n. 1, settembre 2007, pp. 21–6, DOI:10.1002/path.2204, PMID 17614097.
Will RG, Ironside JW, Zeidler M, A new variant of Creutzfeldt–Jakob disease in the UK, in Lancet, vol. 347, n. 9006, aprile 1996, pp. 921–5, DOI:10.1016/S0140-6736(96)91412-9, PMID 8598754.
Chakraborty C, Nandi S, Jana S, Prion disease: a deadly disease for protein misfolding, in Current Pharmaceutical Biotechnology, vol. 6, n. 2, aprile 2005, pp. 167–77, DOI:10.2174/1389201053642321, PMID 15853695.
Graham A Mackay, Richard SG Knight e James W Ironside, The molecular epidemiology of variant CJD, in International Journal of Molecular Epidemiology and Genetics, 2(3), n. 3, 2011, pp. 217–27, PMC 3166149, PMID 21915360.
Manuelidis L, Yu ZX, Barquero N, Banquero N, Mullins B, Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles, in Proceedings of the National Academy of Sciences of the United States of America, vol. 104, n. 6, febbraio 2007, pp. 1965–70, DOI:10.1073/pnas.0610999104, PMC 1794316, PMID 17267596.
Mills JL, Schonberger LB, Wysowski DK, Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients, in The Journal of Pediatrics, vol. 144, n. 4, aprile 2004, pp. 430–6, DOI:10.1016/j.jpeds.2003.12.036, PMID 15069388.
McDonnell G, Burke P, The challenge of prion decontamination, in Clinical Infectious Diseases, vol. 36, n. 9, maggio 2003, pp. 1152–4, DOI:10.1086/374668, PMID 12715310.
Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient, in Lancet, vol. 364, n. 9433, 2004, pp. 527–9, DOI:10.1016/S0140-6736(04)16811-6, PMID 15302196.
Regan F, Taylor C, Blood transfusion medicine, in BMJ (Clinical Research Ed.), vol. 325, n. 7356, luglio 2002, pp. 143–7, DOI:10.1136/bmj.325.7356.143, PMC 1123672, PMID 12130612.
Geoffrey S. Young, G, F, M, H, L, L, W e L, Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt–Jakob Disease: High Sensitivity and Specificity for Diagnosis, in American Journal of Neuroradiology, vol. 26, n. 6, American Society of Neuroradiology, giugno–luglio 2005, pp. 1551–1562, PMID 15956529. URL consultato il 30 ottobre 2007.
Sanchez-Juan, P., Green, A., Ladogana, A., et al., CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease, in Neurology, vol. 67, n. 4, 2006, pp. 637–643, DOI:10.1212/01.wnl.0000230159.67128.00, PMID 16924018.
Tattum, M. H., Jones, S., Pal, S., Khalili-Shirazi, A., Collinge, J., Jackson, G., A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K, in Transfusion, vol. 50, n. 12, AABB, dicembre 2010, pp. 2619–2627, DOI:10.1111/j.1537-2995.2010.02731.x, PMID 20561299.
Belay ED, Schonberger LB, Variant Creutzfeldt–Jakob disease and bovine spongiform encephalopathy, in Clin. Lab. Med., vol. 22, n. 4, 2002, pp. 849–62, v–vi, DOI:10.1016/S0272-2712(02)00024-0, PMID 12489284.
Rainov NG, Tsuboi Y, Krolak-Salmon P, Vighetto A, Doh-Ura K, Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?, in Expert opinion on biological therapy, vol. 7, n. 5, 2007, pp. 713–26, DOI:10.1517/14712598.7.5.713, PMID 17477808.
Pfeifer A, Eigenbrod S, Al-Khadra S, Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice, in The Journal of Clinical Investigation, vol. 116, n. 12, dicembre 2006, pp. 3204–10, DOI:10.1172/JCI29236, PMC 1679709, PMID 17143329.

oadoi.org

Wang XF, Dong CF, Zhang J, Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro, in Mol. Cell. Biochem., vol. 310, 1–2, marzo 2008, pp. 49–55, DOI:10.1007/s11010-007-9664-6, PMID 18038270.
Hamaguchi T, Noguchi-Shinohara M, Nozaki I, The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures, in Neuropathology, vol. 29, n. 5, ottobre 2009, pp. 625-31, DOI:10.1111/j.1440-1789.2009.01023.x, PMID 19659942.
Will RG, Ironside JW, Zeidler M, A new variant of Creutzfeldt–Jakob disease in the UK, in Lancet, vol. 347, n. 9006, aprile 1996, pp. 921–5, DOI:10.1016/S0140-6736(96)91412-9, PMID 8598754.
Chakraborty C, Nandi S, Jana S, Prion disease: a deadly disease for protein misfolding, in Current Pharmaceutical Biotechnology, vol. 6, n. 2, aprile 2005, pp. 167–77, DOI:10.2174/1389201053642321, PMID 15853695.
McDonnell G, Burke P, The challenge of prion decontamination, in Clinical Infectious Diseases, vol. 36, n. 9, maggio 2003, pp. 1152–4, DOI:10.1086/374668, PMID 12715310.
Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient, in Lancet, vol. 364, n. 9433, 2004, pp. 527–9, DOI:10.1016/S0140-6736(04)16811-6, PMID 15302196.
Sanchez-Juan, P., Green, A., Ladogana, A., et al., CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease, in Neurology, vol. 67, n. 4, 2006, pp. 637–643, DOI:10.1212/01.wnl.0000230159.67128.00, PMID 16924018.
Tattum, M. H., Jones, S., Pal, S., Khalili-Shirazi, A., Collinge, J., Jackson, G., A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K, in Transfusion, vol. 50, n. 12, AABB, dicembre 2010, pp. 2619–2627, DOI:10.1111/j.1537-2995.2010.02731.x, PMID 20561299.
Rainov NG, Tsuboi Y, Krolak-Salmon P, Vighetto A, Doh-Ura K, Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?, in Expert opinion on biological therapy, vol. 7, n. 5, 2007, pp. 713–26, DOI:10.1517/14712598.7.5.713, PMID 17477808.

orpha.net

Malattia di Creutzfeldt-Jakob, su Orphanet.

oxfordjournals.org

brain.oxfordjournals.org

Zerr I, Kallenberg K, Summers DM, et al., Updated Clinical Diagnostic Criteria for sporadic Creutzfeldt-Jakob Disease in Brain, vol. 132 (10), 2009, pp. 2659-2668 DOI:10.1093/brain/awp191.

rarediseases.org

Creutzfeldt Jakob Disease, su National Organization of Rare Desease - USA.

trasfusione.ch

svizzera-italiana.trasfusione.ch

Servizio Trasfusionale CRS della Svizzera Italiana | Chi può donare il sangue?, su svizzera-italiana.trasfusione.ch. URL consultato il 21 settembre 2018.

unibo.it

acnpsearch.unibo.it

Obi RK, Nwanebu FC, Prions And Prion Diseases, in African Journal of Clinical and Experimental Microbiology, vol. 9, n. 1, 2008, pp. 38–52, ISSN 1595-689X (WC · ACNP). URL consultato il 20 giugno 2009.
(EN) M.E. Bruce, R.G. Will, J.W. Ironside, I. McConnell, D Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser e C.J. Bostock, Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent, in Nature, vol. 389, n. 6650, NY, NY, Nature Publishing Group, 2 ottobre 1997, pp. 498-501, DOI:10.1038/39057, ISSN 0028-0836 (WC · ACNP). URL consultato il 25 aprile 2012.

utah.edu

library.med.utah.edu

Pathology of Degenerative CNS Diseases.

web.archive.org

CJD (Creutzfeldt-Jakob Disease, Classic), su cdc.gov, Centers for Disease Control and Prevention, 26 febbraio 2008. URL consultato il 20 giugno 2009 (archiviato dall'url originale il 6 maggio 2009).
Creutzfeldt-Jakobs sjukdom, su Socialstyrelsen - Svezia. URL consultato il 2 ottobre 2017 (archiviato dall'url originale il 20 settembre 2017).
vCJD (Variant Creutzfeldt-Jakob Disease), su cdc.gov, Centers for Disease Control and Prevention, 4 gennaio 2007. URL consultato il 20 giugno 2009 (archiviato dall'url originale il 7 maggio 2009).
National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU) Casi totali vCJD per Nazione (PDF) (archiviato dall'url originale il 26 febbraio 2015)., marzo 2014
Questions and Answers: Creutzfeldt–Jakob Disease Infection-Control Practices, su Infection Control Practices/CJD (Creutzfeldt–Jakob Disease, Classic), Centers for Disease Control and Prevention, 4 gennaio 2007. URL consultato il 9 giugno 2007 (archiviato dall'url originale il 17 ottobre 2007).
(EN) Variant CJD and blood donation (PDF), su blood.co.uk, Nayonal blood service - UK. URL consultato il 2 gennaio 2016 (archiviato dall'url originale il 19 aprile 2004).
In-Depth Discussion of Variant Creutzfeld-Jacob Disease and Blood Donation, su redcross.org, American Red Cross. URL consultato il 20 giugno 2009 (archiviato dall'url originale il 30 dicembre 2007).
(DE) Permanent exclusion criteria, su blutspendehamburg.de, Blutspendedienst Hamburg. URL consultato il 20 giugno 2009 (archiviato dall'url originale il 18 luglio 2011).
(PL) INFORMACJE DLA KRWIODAWCÓW (Informazioni per i donatori di sangue), su rckik-warszawa.com.pl, Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Warszawie. URL consultato il 2 gennaio 2016 (archiviato dall'url originale il 1º settembre 2007).
Detecting Prions in Blood (PDF), in Microbiology Today, agosto 2010, p. 195. URL consultato il 21 agosto 2011 (archiviato dall'url originale il 31 marzo 2012).
Ian Bone, Lay summary of a report by Professor Ian Bone: Intraventricular Pentosan Polysulphate in Human Prion Diseases - A study of Experience in the United Kingdom (PDF), su mrc.ac.uk, Medical Research Council - UK. URL consultato il 19 ottobre 2014 (archiviato dall'url originale il 6 marzo 2016).
Use of Pentosan Polysulphate in the treatment of, or prevention of, vCJD, su dh.gov.uk, Department of Health:CJD Therapy Advisory Group. URL consultato il 30 ottobre 2007 (archiviato dall'url originale il 5 luglio 2007).

who.int

WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies, su who.int, World Health Organization: Communicable Disease Surveillance and Control, 26 marzo 1999. URL consultato il 9 giugno 2007.

worldcat.org

Obi RK, Nwanebu FC, Prions And Prion Diseases, in African Journal of Clinical and Experimental Microbiology, vol. 9, n. 1, 2008, pp. 38–52, ISSN 1595-689X (WC · ACNP). URL consultato il 20 giugno 2009.
(EN) M.E. Bruce, R.G. Will, J.W. Ironside, I. McConnell, D Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser e C.J. Bostock, Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent, in Nature, vol. 389, n. 6650, NY, NY, Nature Publishing Group, 2 ottobre 1997, pp. 498-501, DOI:10.1038/39057, ISSN 0028-0836 (WC · ACNP). URL consultato il 25 aprile 2012.